Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers

NCT01383096 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: OZ439 mesylate 800mg Powder in Bottle for Oral Suspension
DRUG: OZ439 mesylate 400mg Prototype Solution Formula 1
DRUG: OZ439 mesylate 800mg Prototype Solution Formula 1
DRUG: OZ439 mesylate 800mg Prototype Solution Formula 2

Sponsor

Medicines for Malaria Venture

Collaborators

[object Object]
[object Object]